Epidermal nevus syndrome is an unusual neurocutaneous disorder in which epidermal nevi are associated with abnormalities of the skeleton and central nervous system, including the eyes and somtimes the cardiovascular system. We treated a patient in whom the latter included renal artery stenosis. An 18-year-old man with epidermal nevi was diagnosed as having the syndrome based on the additional presence of scoliosis, an arachnoid cyst in the middle cranial fossa, and microphthalmos. Hypertension was diagnosed when the patient was 15 years old. The plasma renin activity (9.7 ng/ml/h) was elevated. Right renal artery stenosis was demonstrated by angiography, and the abdominal aorta was narrowed distal to the ostium of the superior mesenteric artery. The plasma renin activity in the right renal vein (16 ng/ml/h) was higher than contralaterally (10 ng/ml/h). Several cardiovascular manifestations have been reported as a complication of epidermal nevus syndrome. Hypertension in an individual with epidermal nevi and congenital anomalies should prompt a search for a vascular anomaly.

Keywords:
Epidermal nevus syndrome, Hypertension, Arterial hypoplasia, Renin-angiotensin system
1.
Kaplan NM: Classification of causes of RVHT: Renal vascular hypertension; in Kaplan NM (ed): Clinical Hypertension, ed. 7. Baltimore, Williams & Wilkins, 1998, pp 303–305.
2.
Solomon LM, Fretzin DF, Dewald RL: The epidermal nevus syndrome. Arch Dermatol 1968;97:273–285.
3.
Grebe TA, Rimsza ME, Richter SF, Hansen RC, Hoyme HE: Further delineation of the epidermal nevus syndrome: Two cases with new findings and literature review. Am J Med Genet 1993;47:24–30.
4.
Rogers M, McCrossin I, Commens C: Epidermal nevi and the epidermal nevus syndrome: A review of 131 cases. J Am Acad Dermatol 1989;20:476–488.
5.
Radin R, David CL, Goldfarb H, Francis IR: Adrenal and extra-adrenal retroperitoneal ganglioneuroma: Imaging findings in 13 adults. Radiology 1997;202:703–707.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.